In a tragic accident in Chapel Hill, North Carolina, the life of a prominent biopharmaceutical CEO was tragically cut short in a devastating car crash.
A biopharmaceutical company’s CEO lost her life in a horrific car collision on Tuesday. The Town of Chapel Hill identified the victims as 50-year-old Carrboro resident Lisa Marie Yanez and 40-year-old Durham resident Vaughn Avery Booker. The devastating crash occurred when the vehicle struck a tree, claiming the lives of both the driver and passenger on the scene, according to the Chapel Hill Police Department’s investigation as reported by Daily Tar Heel.
While the investigation into the cause of the accident is still underway, the Town of Chapel Hill has yet to release any new information. Lisa Yanez held the position of CEO at Aerami Therapeutics, a clinical-stage biopharmaceutical firm committed to developing treatments for serious cardiopulmonary and cardiometabolic conditions.
In a heartfelt news release, the company expressed their profound sorrow over the loss of their friend, passionate patient advocate, dedicated mentor, and CEO.
The entire Aerami community is mourning the loss of Lisa and extending their deepest condolences to her family during this challenging time. Described as possessing boundless empathy, intellect, bravery, and compassion, Lisa’s career was marked by her insatiable curiosity and desire to help others. However, her family was always her top priority. The thoughts of the Aerami community are with Lisa’s loved ones and the many friends and colleagues she leaves behind.
In the wake of this tragedy, Anne Whitaker, the current Executive Chairwoman of the Board of Directors, will step in as Aerami’s CEO to ensure a smooth transition and the continuation of the company’s operations.
Whitaker expressed her grief over the loss of Lisa Yanez, remembering her as a passionate, genuine leader who worked tirelessly alongside her colleagues to improve people’s lives. Whitaker feels privileged to have known Lisa as both a colleague and a friend. In honoring Lisa’s legacy, Whitaker is confident that she and the dedicated Aerami leadership team will continue their commitment to their pulmonary hypertension clinical programs and their focus on enhancing the lives of the patients they serve.
Sources: TheGatewayPundit, Daily Tar Heel